These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8196318)

  • 1. [Use of fragmin (low-molecular-weight heparin) in patients with unstable angina].
    Kirichenko AA; Repinskaia NP; Prekina VI
    Klin Med (Mosk); 1994; 72(1):27-30. PubMed ID: 8196318
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of fraxiparin on thrombocytic-vascular hemostasis in patients with unstable stenocardia].
    Timofeeva AV; Dobrotvorskaia TE; Dolgov VV; Arifullin ShS
    Ter Arkh; 1993; 65(8):16-7. PubMed ID: 8211793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of dalteparin and enoxaparin on hemostatic parameters and von Willebrand factor in patients with unstable angina pectoris or non--ST- segment elevation acute myocardial infarction.
    Hödl R; Huber K; Kraxner W; Nikfardjam M; Schumacher M; Fruhwald FM; Zorn G; Wonisch M; Klein W
    Am J Cardiol; 2002 Mar; 89(5):589-92. PubMed ID: 11867046
    [No Abstract]   [Full Text] [Related]  

  • 4. Fragmin in unstable angina pectoris or in non-Q-wave acute myocardial infarction (the FRIC study). Fragmin in Unstable Coronary Artery Disease.
    Klein W; Buchwald A; Hillis WS; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Am J Cardiol; 1997 Sep; 80(5A):30E-34E. PubMed ID: 9296467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy of unstable angina with the low molecular weight heparins.
    Ageno W; Turpie AG
    Vasc Med; 2000; 5(4):217-23. PubMed ID: 11213233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chrono-pharmacological study of once daily curative dose of a low molecular weight heparin (200 IU antiXa/kg of Dalteparin) in ten healthy volunteers.
    Mismetti P; Reynaud J; Tardy-Ponce B; Laporte-Simitsidis S; Scully M; Goodwyn C; Queneau P; Decousus H
    Thromb Haemost; 1995 Aug; 74(2):660-6. PubMed ID: 8585003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Heparin in the treatment of unstable angina. Can the decrease of the molecular size increase its effectiveness?].
    Panchenko EP
    Ter Arkh; 1998; 70(12):71-4. PubMed ID: 10067259
    [No Abstract]   [Full Text] [Related]  

  • 8. Enoxaparin and dalteparin in unstable angina: new indication. Enoxaparin: a reference treatment. Dalteparin: no better than unfractionated heparin.
    Prescrire Int; 1999 Jun; 8(41):77-80. PubMed ID: 10558446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide-challenge in patients with unstable angina.
    Kälsch T; Nguyen XD; Elmas E; Grebert N; Süselbeck T; Klüter H; Borggrefe M; Dempfle CE
    Int J Cardiol; 2006 Aug; 111(2):217-23. PubMed ID: 16182391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular weight heparin reduces the generation and activity of thrombin in unstable coronary artery disease.
    Ernofsson M; Strekerud F; Toss H; Abildgaard U; Wallentin L; Siegbahn A
    Thromb Haemost; 1998 Mar; 79(3):491-4. PubMed ID: 9531028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of fragmin, a low-molecular heparin, on hemostasis in patients with alimentary-constitutional obesity].
    Kuzin MI; Kuzin NM; Markov NK; Leont'eva MS; Gorbatov OI; Romanov MM; Shumbalina LF; Nesterova SG
    Khirurgiia (Mosk); 1993 Oct; (10):29-34. PubMed ID: 8295379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina].
    Godoy I; Herrera C; Zapata C; Kunstmann S; Abufhele A; Corbalán R
    Rev Med Chil; 1998 Mar; 126(3):259-64. PubMed ID: 9674294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J; Johnston N; Siegbahn A
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G; Brenot F; Pacouret G; Simonneau G; Gillet Juvin K; Charbonnier B; Sors H
    Thromb Haemost; 1995 Dec; 74(6):1432-5. PubMed ID: 8772215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism.
    Antovic A; Blombäck M; Bremme K; He S
    Blood Coagul Fibrinolysis; 2002 Apr; 13(3):181-6. PubMed ID: 11943930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of various drugs on rheological properties of the blood and hemostasis in patients with unstable stenocardia].
    Orlov VA; Iakunin GA; Khishtovani AI
    Klin Med (Mosk); 1987 Apr; 65(4):31-6. PubMed ID: 3599852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.